Pain relief for carpal tunnel syndrome using Dexmedetomidine, Ozone, and Dexamethasone injections
Official title: A Comparative Study Between Dexmedetomidine, Ozone and Dexamethasone Local Injection in Carpal Tunnel Syndrome for Long- Term Pain Relief
Run by Tanta University · NCT06133712 · Data updated 2026-11-12
This study is testing a new combination of injections to see if it can relieve pain better for people with carpal tunnel syndrome compared to standard treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 60 Years |
| Sex | All |
| Enrollment | 135 (estimated) |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta, El Gharbia) |
| Status | Recruiting |
| Started | November 1, 2023 |
| Main results expected | December 1, 2025 |
| Study ends | December 1, 2025 |
| Registry record updated | May 29, 2025 |
| Trial ID | NCT06133712 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 20 to 60 with mild-to-moderate carpal tunnel syndrome symptoms persisting for at least three months.
✕Probably not a fit
Patients with severe carpal tunnel syndrome or those who have previously undergone surgery or injections for CTS may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of a combination of Dexmedetomidine, Ozone, and Dexamethasone injections for pain relief in patients with carpal tunnel syndrome (CTS). CTS is characterized by symptoms related to median nerve compression at the wrist, and current treatments often involve corticosteroid injections. The study will include patients aged 20 to 60 with mild-to-moderate CTS, confirmed by ultrasound and nerve conduction studies. The goal is to determine if this novel combination therapy provides better analgesic outcomes compared to standard treatments.
Why it matters
Potential benefit: If successful, this approach could offer a more effective pain relief option for patients suffering from carpal tunnel syndrome.
How similar studies have gone: While corticosteroid injections are a standard treatment for CTS, the combination of Dexmedetomidine and Ozone is a novel approach that has not been widely tested in similar studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age from 20 to 60 years. * Both sexes. * Patients with ultrasonographic evidence of mild-to-moderate carpal tunnel syndrome (CTS). * Inclusion criteria will include numbness and pain in the median nerve (MN) distribution persisting for minimum of 3 months , nerve conduction studies (NCS) consistent with carpal tunnel syndrome (CTS) as per the American Association of Neuromuscular and Electro diagnostic Medicine (AANEM) guidelines, and an median nerve (MN) cross-sectional area (CSA)at the wrist \>12 mm2 suggesting mild-to-moderate CTS forms. Exclusion Criteria: * Patient refusal. * Patients with severe symptoms and signs of CTS as identified per the American Association of Neuromuscular and Electro diagnostic Medicine (AANEM) guidelines,\[14\] as this is an indication for surgery, * Patients who show improvement on medical treatment, * Previous surgical or injectional CTS treatment, * Pregnancy ,co existence of brachial plexopathy, or thoracic outlet syndrome, polyneuropathy, radiculopathy and peripheral nerve lesion in upper limb. * Severe cardiovascular disease * Morbid obese patients (body mass index (BMI) of \>35 kg/m2) * Infection at site of injection. * Bleeding diathesis. * History of thyroid deficiency, uncontrolled diabetes mellitus , rheumatoid arthritis and history of glucose-6-phosphate dehydrogenase (G6PD) deficiency * History of Ozone or Dexmedetomidine allergy. * End stage renal and hepatic disease. * History of inflammatory joint , connective tissue disorders, , burns, any local tissue contractures and history of wrist trauma. * Patients who will not consent to completing The visual analogue scale (VAS) for pain or nerve conduction study before and after injection.
Where it's running
-
Faculty of Medicine
Tanta, El Gharbia, Egypt Recruiting
Study contacts
- Principal investigator: Mahmoud Elgebaly, Md — Tanta faculty of medicine
- Study coordinator: Mahmoud T Elgebaly, MD
- Email: mahmoud.talaat@med.tanta.edu
- Phone: 00201092415231
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dexamethasone, Dexmedetomidine, or Both After Laparoscopic Gallbladder Surgery
This study tests whether dexamethasone, dexmedetomidine, or the combination help recovery of gut function after laparoscopic cholecystectomy.
-
Dexmedetomidine to See if Delirium Drops After Hip Fracture Surgery
This observational study tests whether using dexmedetomidine around hip fracture surgery helps prevent postoperative delirium in adults 65 and older.
-
Esmolol vs Dexmedetomidine for opioid-sparing in laparoscopic gynecologic surgery
This study tests whether low-dose esmolol or dexmedetomidine, given during surgery, reduces opioid use and improves pain control after laparoscopic hysterectomy compared with placebo.
-
Dexamethasone and Spinal Block Duration in Lower Abdominal Surgery
This study tests whether giving dexamethasone before spinal anesthesia can lengthen how long the numbness lasts for adults having lower abdominal surgery.
-
Dexmedetomidine with taVNS to see if PTSD after trauma surgery can be reduced
This study tests whether giving dexmedetomidine together with transcutaneous vagus nerve stimulation after emergency trauma surgery can lower the chances of developing PTSD.
-
Intraparotid injection of bupivacaine with dexamethasone after partial parotidectomy
This early-phase study tests whether a single intraparotid injection of bupivacaine with dexamethasone is safe and tolerable after partial parotidectomy for a benign tumor.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.